The Titan Versus Everolimus Intracoronary Stent (Xience V) in Diabetic Patients

Exclusion Criteria

• •Inclusion in another clinical research protocol
• •Pregnancy
• •STEMI within 48 hours
• •Unprotected left main disease
• •Restenotic lesions
• •Stent diameter \< 2,5 mm or \> 3,5 mm
• •Stent length more than 28 mm in \< 3 mm vessels
• •Chronic total occlusions
• •Allergy to aspirin, clopidogrel, heparin or abciximab
• •Active bleeding or a significant increase in bleeding risk
• •Significant renal insufficiency defined as creatinine \> 2 mg/dl
• •Severely depressed LV function (EF≤35%)
• •Cardiogenic shock
• •Ischemic stroke within the last 6 months
• •Contraindication for DES
• •Disease with life expectancy \< 12 months